148 related articles for article (PubMed ID: 25322975)
41. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
[TBL] [Abstract][Full Text] [Related]
42. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
[TBL] [Abstract][Full Text] [Related]
43. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
44. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
Al-Farra HM; Al-Fahoum SK; Tabbaa MA
Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
[TBL] [Abstract][Full Text] [Related]
45. Determinants of hormonal replacement therapy in recently postmenopausal women.
Ringa V; Ledésert B; Gueguen R; Schiele F; Breart G
Eur J Obstet Gynecol Reprod Biol; 1992 Jul; 45(3):193-200. PubMed ID: 1511767
[TBL] [Abstract][Full Text] [Related]
46. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.
McMenamin Ú; Hicks B; Hughes C; Murchie P; Hippisley-Cox J; Ranger T; Coupland C; Cardwell C
BMC Cancer; 2021 Mar; 21(1):313. PubMed ID: 33761919
[TBL] [Abstract][Full Text] [Related]
47. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
48. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
Martin-Du Pan RC; Luzuy F
Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
[TBL] [Abstract][Full Text] [Related]
49. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
Gambrell RD; Natrajan PK
Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
[TBL] [Abstract][Full Text] [Related]
50. Hormone replacement therapy in postmenopausal women.
Prelevic GM; Kocjan T; Markou A
Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
[TBL] [Abstract][Full Text] [Related]
51. [Hormone replacement therapy for internal risk patients].
Mueck AO
Gynakol Geburtshilfliche Rundsch; 2006; 46(4):174-90. PubMed ID: 17068402
[TBL] [Abstract][Full Text] [Related]
52. [Hormone replacement therapy and cardio-vascular disease].
Lesiak M; Mariola RL; Podkowa N
Ginekol Pol; 2016; 87(1):59-64. PubMed ID: 27306470
[TBL] [Abstract][Full Text] [Related]
53. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
54. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
55. Hormone replacement therapy and cardiovascular health in the United States.
Shetty KD; Vogt WB; Bhattacharya J
Med Care; 2009 May; 47(5):600-6. PubMed ID: 19319001
[TBL] [Abstract][Full Text] [Related]
56. Hormone replacement therapy and cardiovascular disease.
Samsioe G
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():23-9. PubMed ID: 8499956
[TBL] [Abstract][Full Text] [Related]
57. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
Abramson BL
J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
[TBL] [Abstract][Full Text] [Related]
58. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
[TBL] [Abstract][Full Text] [Related]
59. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
Bernardi F; Pieri M; Stomati M; Luisi S; Palumbo M; Pluchino N; Ceccarelli C; Genazzani AR
Gynecol Endocrinol; 2003 Feb; 17(1):65-77. PubMed ID: 12724021
[TBL] [Abstract][Full Text] [Related]
60. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
